Vanguard Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Vanguard Capital Management's VCYT Position: Q3 2026 in Review
Vanguard Capital Management increased its Veracyte (VCYT) stake by 0.18% in Q3 2026, buying an estimated $309K and bringing the position to 3,600,336 shares worth $166M. The position accounts for ﹤0.01% of the portfolio, ranked #1223.
Vanguard Capital Management first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $211M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Vanguard Capital Management held 3,600,336 shares of Veracyte worth $166M as of Q3 2026.
- Vanguard Capital Management bought 6,414 Veracyte shares in Q3 2026, an estimated $309K.
- Veracyte made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1223 holding.
- Vanguard Capital Management first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Veracyte position peaked at $211M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.